“… 10 , 11 Indeed, NGS is a fascinating tool that enables cytopathologists to analyse different biomarkers simultaneously, even when the starting material features a low tumour content. 10 , 11 , 12 In particular, NGS technologies are based on three main sequencing approaches: by synthesis, by hybridisation, and by ligation. 13 In spite of these differences, all three approaches employ the same exact four‐step workflow: (a) library generation; (b) clonal amplification of the single generated fragments; (c) massive parallel sequencing, and (d) data analysis.…”